Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 19, Number 10—October 2013

Research

Emergence of Vaccine-derived Polioviruses, Democratic Republic of Congo, 2004–2011

Nicksy GumedeComments to Author , Olivia Lentsoane, Cara C. Burns, Mark Pallansch, Esther de Gourville, Riziki Yogolelo, Jean Jacques Muyembe-Tamfum, Adrian Puren, Barry D. Schoub, and Marietjie Venter
Author affiliations: National Institute for Communicable Diseases, Johannesburg, South Africa (N. Gumede, O. Lentsoane, A. Puren, B.D. Schoub, M. Venter); University of Witwatersrand, Johannesburg (N. Gumede, B.D. Schoub); University of Pretoria, Pretoria, South Africa (M. Venter); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (C.C. Burns, M. Pallansch); World Health Organization, Geneva, Switzerland (E. de Gourville); National Institute for Biomedical Research, Kinshasa/Gombe, Democratic Republic of Congo (R. Yogolelo, J.J. Muyembe-Tamfum)

Main Article

Figure 2

Yearly incidence of vaccine-derived polivirus type 2, Democratic Republic of Congo, 2004–2011. The total number of cases associated with vaccine-derived polivirus type 2 is graphed for each year according to date of onset of paralysis. Viruses that are not assigned to a lineage are categorized as unclassified. VDVPs, vaccine-derived PVs.

Figure 2. . Yearly incidence of vaccine-derived polivirus type 2, Democratic Republic of Congo, 2004–2011. The total number of cases associated with vaccine-derived polivirus type 2 is graphed for each year according to date of onset of paralysis. Viruses that are not assigned to a lineage are categorized as unclassified. VDVPs, vaccine-derived PVs.

Main Article

TOP